Bionano, Nvidia collaborate on data processing solution for genome mapping tool

Bionano Genomics (NASDAQ:BNGO) is collaborating with Nvidia (NVDA) to develop an acceleration platform for use in Bionano's optical genome mapping (OGM) workflow.
The collaboration is expected to improve data processing speed while reducing time and cost linked with secondary analysis of OGM data.
The partnership will use By combining Nvidia's expertise in accelerated computing and the NVIDIA RTX 6000 Ada Generation professional GPU with Bionano's knowledge in extraction, enzymatic treatment, and analysis of ultra-high molecular weight (UHMW) DNA molecules.
The solution is projected to support analysis of 96 cancer workflows or about 300 constitutional whole genomes per week and be integrated with Bionano's NxClinical software for variant interpretation and reporting, the company noted.
The collaboration aims to develop on-premise and cloud-based solutions to keep pace with the data generation needs of high-throughput OGM workflows, the company added.
"Bionano’s optical genome mapping platform provides tremendous capability for genome-wide structural variant detection, which can have huge impact for cancer research and other areas of human health," said George Vacek, global head of genomics alliances at Nvidia.
BNGO -0.56% to $1.79 premarket Jan. 12